title: Should we lower the age for routine HPV vaccination in the United States?
authors.affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA; Division of Cancer Epidemiology, McGill University, Montreal, Canada. Electronic address: joseph.tota@nih.gov.
authors.forename: Joseph E
authors.initials: JE
authors.lastname: Tota
authors.affiliation: Division of Cancer Epidemiology, McGill University, Montreal, Canada.
authors.forename: Sandra D
authors.initials: SD
authors.lastname: Isidean
authors.affiliation: Division of Cancer Epidemiology, McGill University, Montreal, Canada.
authors.forename: Eduardo L
authors.initials: EL
authors.lastname: Franco
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002648:Child; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D014481:United States; D002583:Uterine Cervical Neoplasms; D014611:Vaccination; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines
keywords: Age; Human papillomavirus; Vaccination